COVID, IVERMECTIN and VACCINE Information Full Feature Documentary
- Thread starter Mixd
- Start date
-
- Tags
- covid ivermectin vaccines
That's miss leading. He's comparing vaccinated people to vaccinated people. Unvaccinated are still dying at a much higher rate.
That's miss leading. He's comparing vaccinated people to vaccinated people. Unvaccinated are still dying at a much higher rate.
Was that study done at Social Media University?
But the assertion that vaccines are ineffective because the majority of people dying from COVID-19 are vaccinated is flawed. The rate of death among the vaccinated is still significantly lower than the unvaccinated. The vaccinated comprise the majority of deaths because such a high percentage of the population has been vaccinated
Fact check: Belief COVID-19 vaccines are not effective comes from misinterpreted data
More vaccinated people die of COVID-19 in terms of raw numbers, but only because so many are vaccinated. Unvaccinated still die at a higher rate.
www.usatoday.com
COVID-19 Deaths by Vaccination Status Dashboard | Texas DSHS
Fact Check-Finding that most people dying from COVID-19 are vaccinated does not mean vaccines don’t work
Statistics that show the majority of deaths from COVID-19 are among vaccinated people reflect the fact most people are vaccinated, not that the vaccines are ineffective, as implied in a social media post. Similar statistics show COVID vaccines continue to reduce the risk...
www.reuters.com
COVID and the Heart: It Spares No One | Johns Hopkins Bloomberg School of Public Health
New evidence suggests anyone infected with COVID is at higher risk for heart issues—a risk that persists even in relatively healthy people long after the illness has passed.
Smidt Heart Institute Researchers Show the Risk of Developing Postural Orthostatic Tachycardia Syndrome, or POTS, Is Five Times Higher After COVID-19 Than After Vaccination
www.cedars-sinai.org
COVID Infection, Vaccination Linked to Heart Condition
Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.Their findings, published in the peer-reviewed journal Nature...
Heart Problems after COVID-19
Chest pain, shortness of breath and palpitations can persist after COVID-19. Are they heart related? A cardiologist provides perspective.
Still, COVID-19 vaccines do have a rare but worrisome cardiac side effect. Myocarditis, an inflammation of the heart muscle that can cause chest pain and shortness of breath, has disproportionately struck older boys and young men who received the shots. Only one out of several thousand in those age groups is affected, and most quickly feel better. A tiny number of deaths have been tentatively linked to vaccine myocarditis around the world. But several new studies suggest the heart muscle can take months to heal, and some scientists worry about what this means for patients long term.
www.science.org
Science | AAAS
Of the hundreds of millions of Covid vaccine doses given in the U.S. since late 2020, there have been around 1,000 reports of vaccine-related myocarditis or pericarditis in children under age 18, primarily young males, according to the Centers for Disease Control and Prevention. Most of those who developed the condition have fully recovered, although research so far has only looked at how well they're doing after several months. Some doctors wonder if it can cause permanent damage to the heart.
www.nbcnews.com
Are there long-term myocarditis risks after Covid vaccination?
Both Pfizer and Moderna are launching clinical trials to track health issues — if any — in the years following a diagnosis of vaccine-associated heart problems in teens and young adults.
www.nbcnews.com
large study investigating potential repurposed treatments for COVID-19 has found no benefit for ivermectin in reducing a person’s risk of being hospitalized or dying from the disease, according to a preprint posted by the researchers on medRxiv yesterday (June 12). The randomized placebo-controlled trial included more than 1,500 people, and adds to a growing body of research suggesting the antiparasitic drug is unlikely to be effective at staving off disease progression.
“Overall, most people improved their symptoms whether they took ivermectin or not,” study coauthor Adrian Hernandez, executive director of the Duke Clinical Research Institute, says in a press statement. He adds that “there does not appear to be a role for ivermectin outside of a clinical trial setting, especially considering other available options with proven reduction in hospitalizations and death.”
www.the-scientist.com
“Overall, most people improved their symptoms whether they took ivermectin or not,” study coauthor Adrian Hernandez, executive director of the Duke Clinical Research Institute, says in a press statement. He adds that “there does not appear to be a role for ivermectin outside of a clinical trial setting, especially considering other available options with proven reduction in hospitalizations and death.”
No Reduction in COVID-19 Hospitalizations, Deaths with Ivermectin
The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.
www.the-scientist.com
In an article recently published in the Journal of the American Medical Association (JAMA), the researchers concluded that taking 400 mcg/kg ivermectin for three days, when compared with a placebo, did not significantly improve the chances for a patient with mild to moderate symptoms of COVID-19 to avoid hospitalization.
The use of ivermectin also showed no measurable decrease in the severity of COVID-19 symptoms or the length of time these patients experienced COVID-19 symptoms.
“The most important takeaway from the study is that ivermectin does not help improve outcomes from COVID-19 infection and thus should not be used as a treatment for COVID-19,” said Tiffany Schwasinger-Schmidt, M.D., Ph.D., associate professor of internal medicine at the University of Kansas School of Medicine-Wichita, director of the Center for Clinical Research and site director of the study for the KU Medical Center location in Wichita.
www.kumc.edu
The use of ivermectin also showed no measurable decrease in the severity of COVID-19 symptoms or the length of time these patients experienced COVID-19 symptoms.
“The most important takeaway from the study is that ivermectin does not help improve outcomes from COVID-19 infection and thus should not be used as a treatment for COVID-19,” said Tiffany Schwasinger-Schmidt, M.D., Ph.D., associate professor of internal medicine at the University of Kansas School of Medicine-Wichita, director of the Center for Clinical Research and site director of the study for the KU Medical Center location in Wichita.
Ivermectin shown ineffective in treating COVID-19, according to multi-site study including KU Medical Center
Results of the study of the antiparasitic medication, once a much-discussed potential treatment for COVID-19, were published in the Journal of the American Medical Association.
Our study was about the association of Ivermectin with reduction in mortality in COVID, a retrospective study with many limitations (which is innate in these types of studies). As in any retrospective study, we could not control for all the confounding variables, mainly severity of disease in patients treated with either ivermectin or remdesivir. Another important caveat is that it was conducted in July 2021, eight months ago, when we did not have all the clinical evidence we have right now about ivermectin in COVID-19. We were very clear in the abstract conclusions that our results are only showing an “association”, they are not definitive, and further randomized clinical trials must be done to prove the efficacy of Ivermectin.
However, the study has been misinterpreted by a significant number of people in the scientific community and the general population, stating that based on our study, ivermectin is effective to reduce COVID-19 mortality. We are really concerned about this problem because the patients may start taking or demanding this medication from their physicians, which can potentially be harmful. We know that a retrospective study like ours cannot be used to change or guide clinical practice. Retrospective studies are only helpful to formulate hypothesis that can be utilized to design clinical trials.
This misrepresentation of the study may lead to a huge public health problem, since Ivermectin is a medication that is not FDA approved for COVID treatment, and currently has proven to be ineffective in clinical trials, which are truly the gold standard to evaluate the efficacy of a medication.
www.sciencedirect.com
However, the study has been misinterpreted by a significant number of people in the scientific community and the general population, stating that based on our study, ivermectin is effective to reduce COVID-19 mortality. We are really concerned about this problem because the patients may start taking or demanding this medication from their physicians, which can potentially be harmful. We know that a retrospective study like ours cannot be used to change or guide clinical practice. Retrospective studies are only helpful to formulate hypothesis that can be utilized to design clinical trials.
This misrepresentation of the study may lead to a huge public health problem, since Ivermectin is a medication that is not FDA approved for COVID treatment, and currently has proven to be ineffective in clinical trials, which are truly the gold standard to evaluate the efficacy of a medication.
RETRACTED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdr…
N-ACETYL CYSTEINE (NAC): Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews
Learn more about N-ACETYL CYSTEINE (NAC) uses, effectiveness, possible side effects, interactions, dosage, user ratings and products that contain N-ACETYL CYSTEINE (NAC).
www.webmd.com
N-acetyl cysteine (NAC) comes from the amino acid L-cysteine. Amino acids are building blocks of proteins. NAC has many uses and is an FDA approved drug.
N-acetyl cysteine is an antioxidant that might play a role in preventing cancer. As a drug, it's used by healthcare providers to treat acetaminophen (Tylenol) poisoning. It works by binding the poisonous forms of acetaminophen that are formed in the liver.
People commonly use N-acetyl cysteine for cough and other lung conditions. It is also used for flu, dry eye, and many other conditions, but there is no good scientific evidence to support many of these uses. There is also no good evidence to support using N-acetyl cysteine for COVID-19.
At the same time, a single-center, double-blind, randomized, placebo-controlled trial conducted in Brazil reported negative results. However, this study evaluated the effect of NAC given as a single dose of 21 g (approximately 300 mg/Kg) for 20 h. The authors did not observe differences between the two groups in the primary end-point of needing invasive mechanical ventilation, or in secondary end-points such as mortality, ICU admission, or time on invasive mechanical ventilation [42].
Another study, which included 92 patients with COVID-19 and ARDS (47 assigned to NAC and 45 assigned to placebo), also found no difference in mortality at 28 days in the group treated with intravenous NAC at a dose of 40 mg/kg/day during 3 consecutive days [43].
Compared to these studies, with a very short administration period, there are positive results with longer dosages. In a randomized study that recruited 46 patients with COVID-19-associated pneumonia, Gaynitdinova et al. [44] analyzed the effect of adding NAC (1200–1500 mg intravenously) to the standard treatment. The group treated with NAC showed a significant increase in blood oxygen saturation and a decrease in CRP values and hospital stay.
These findings were accompanied by a reduction in lung lesions assessed by computed tomography. The efficacy of NAC at a dose of 600 mg every 12 h orally for 14 days was retrospectively evaluated for the prevention of ARDS (PO2/FiO2 <150), the need of mechanical ventilation and mortality at 14 and 28 days. In the group treated with NAC (42 patients out of 82), compared to the group without NAC, a statistically significant reduction was observed in the development of ARDS, the need for mechanical ventilation, and mortality.
This improvement was accompanied by better oxygenation and a reduction in inflammatory markers, such as the number of leukocytes, CRP, or D-dimer values, assuming an anti-inflammatory effect as the cause of this clinical benefit. Recently, Frades et al. examined 274 patients admitted to an Intermediate Respiratory Care Unit with severe respiratory failure due to pneumonia caused by SARS-CoV-2. Their results were consistent with previous data, so that corticosteroids and anticoagulants were associated with better results. Although not statistically significant in the adjusted models, the authors found a benefit of NAC on survival, which they postulate could be due to the improvement in secretion density and its antioxidant effect. Another retrospective study did not show an impact of a five-day regimen of NAC on in-hospital mortality or ICU admission, but NAC shortened the length of hospital stay in patients with SARS-CoV-2 pneumonia.
Similarly, the case-control study conducted by Avdeev et al. [9] showed that an intravenous dose of 1200–1800 mg/day of NAC led to significant improvement in oxygenation parameters and reduction in CRP, clinical deterioration, and length of hospitalization in patients with COVID-19. Both in this study and in the previous ones, the level of evidence did not allow to establish categorical recommendations, which can only be made with data from controlled clinical trials.
www.sciencedirect.com
Another study, which included 92 patients with COVID-19 and ARDS (47 assigned to NAC and 45 assigned to placebo), also found no difference in mortality at 28 days in the group treated with intravenous NAC at a dose of 40 mg/kg/day during 3 consecutive days [43].
Compared to these studies, with a very short administration period, there are positive results with longer dosages. In a randomized study that recruited 46 patients with COVID-19-associated pneumonia, Gaynitdinova et al. [44] analyzed the effect of adding NAC (1200–1500 mg intravenously) to the standard treatment. The group treated with NAC showed a significant increase in blood oxygen saturation and a decrease in CRP values and hospital stay.
These findings were accompanied by a reduction in lung lesions assessed by computed tomography. The efficacy of NAC at a dose of 600 mg every 12 h orally for 14 days was retrospectively evaluated for the prevention of ARDS (PO2/FiO2 <150), the need of mechanical ventilation and mortality at 14 and 28 days. In the group treated with NAC (42 patients out of 82), compared to the group without NAC, a statistically significant reduction was observed in the development of ARDS, the need for mechanical ventilation, and mortality.
This improvement was accompanied by better oxygenation and a reduction in inflammatory markers, such as the number of leukocytes, CRP, or D-dimer values, assuming an anti-inflammatory effect as the cause of this clinical benefit. Recently, Frades et al. examined 274 patients admitted to an Intermediate Respiratory Care Unit with severe respiratory failure due to pneumonia caused by SARS-CoV-2. Their results were consistent with previous data, so that corticosteroids and anticoagulants were associated with better results. Although not statistically significant in the adjusted models, the authors found a benefit of NAC on survival, which they postulate could be due to the improvement in secretion density and its antioxidant effect. Another retrospective study did not show an impact of a five-day regimen of NAC on in-hospital mortality or ICU admission, but NAC shortened the length of hospital stay in patients with SARS-CoV-2 pneumonia.
Similarly, the case-control study conducted by Avdeev et al. [9] showed that an intravenous dose of 1200–1800 mg/day of NAC led to significant improvement in oxygenation parameters and reduction in CRP, clinical deterioration, and length of hospitalization in patients with COVID-19. Both in this study and in the previous ones, the level of evidence did not allow to establish categorical recommendations, which can only be made with data from controlled clinical trials.
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19) and can be associated with serious c…
Last edited:
I noticed I only got brain fog when it was really cloudy and in winter cold months, never in the summer when I was out
and about more,
I started taking vid D supplements then I remember Ma Dukes used to give us cod liver oil three times a week every winter,
I picked up some cod liver oil, add that to the arsenal,
knocked that shit right out, all these symptoms are due to us being sprayed like roaches..
they call it.. Stratospheric Aerosol Injections..
aka spray the population like roaches so they can think they have covid symptoms..
but chea.. ViT D and or Cod Liver oil worked wonders for that shit...
fresh green juice, with parsley, apples , ginger, lemon, work excellent for an energy boost,
way better than coffee... in the morning.... and unlike coffee leaves your breath smellin
nice...
I used to get sinus infections. Only steroids helped reduce the swelling and that cleared the brain fog. Now I have to Flonase everyday. But I good now.
They gonna really come after the WU aka
Wise UNVAXXED!! now, you got that treaudu faggot in canada,
talkin about... The Wise Unvaxxxed need psychiatric help... when
its thier greed and obedience to evil that needs the therapy,
they KNOW the heat is coming, because sentiment like this is picking up
steam and NOT going to stop..
Wise UNVAXXED!! now, you got that treaudu faggot in canada,
talkin about... The Wise Unvaxxxed need psychiatric help... when
its thier greed and obedience to evil that needs the therapy,
they KNOW the heat is coming, because sentiment like this is picking up
steam and NOT going to stop..
They are going HARD trying to get over as much as they can
as long as this bought and sold biden administration is in power,
folks have zero idea how much these industrial complex's from
Medical to Military to Banking...
are doing whatever the fuck they want at the peoples expense.
The fact they keep calling this experimental drug a "vaccine"
Is THE START OF THE MIND FUCKERY!!
Bruh if so, that fag is truly disgusting,
he thinks that shit is so funny he cant keep the fuckin
faggot smirk off his faggot face...
Im telling people look up to scum like him because,
of is "educated" and has a high paying job...
you have to really be a soulless fucktard,
to think playing with peoples health simply for profit is
funny!!
Who is "Jordon Trishton Walker"?
Project Veritas recently released a video featuring "Jordon Trishton Walker," Pfizer executive who revealed shocking new info. But finding anything about him is tough. Here is what I've found so far.
brianoshea.substack.com
BRUH,
this is supposed to be a professional...
and he went full reality show ghetto fagulous...
he was like I was on a date, then he realized how
exposed he was, willing to run his mouth, because
he is ON a date, he felt so fuckin stupid, he didnt know what to do,
he thinks he is in the fuckin eighties, like destroying the recording,
device is going to destroy some TANGIBLE film ... muthafucka,
this is the cloud storage age, that footage been stored up...
the best he shouldve did was just said no comment..
Left, and called corporate immediately but Im glad,
his soulless ass didnt..
He needed to exposed...and his faggot emotional ass,
getting busted was great entertainment...
fag didnt even realize his actions were just gonna make
their rating higher...
He is in trouble because Im sure he signed a contract and was
talking way more than he was supposed to..
He about to get them walking papers from pfizer...
This probably happened days or so ago. I'm sure he quit already or went to his superiors and told on himself already and they probably let him go or something.
DailyMail put out an article from Pfizer stating they are manipulating the virus then reworded the title and article.
Here's their changed article:
More than 150 experts call for gain of function research to CONTINUE because it's essential for 'responding rapidly to emerging viral threats' - despite fears it led to Covid pandemic
By Cassidy Morrison Senior Health Reporter updated 12:47 EST 26 Jan 2023
150 experts call for MORE risky gain of function research
A swath of researchers from the US and UK are pressuring lawmakers to accept controversial gain of function research as a valuable part of scientific discovery at labs such as one at Boston University.
===============================
Then on another note another young athlete...
Unknown his cause of death yet
Last edited:
